Page last updated: 2024-10-25

deferiprone and Nervous System Diseases

deferiprone has been researched along with Nervous System Diseases in 2 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Economou, M1
Teli, A1
Gourtsa, V1
Vargiami, E1
Zafeiriou, D1
Taher, A1
Sheikh-Taha, M1
Koussa, S1
Inati, A1
Neeman, R1
Mourad, F1

Trials

1 trial available for deferiprone and Nervous System Diseases

ArticleYear
Comparison between deferoxamine and deferiprone (L1) in iron-loaded thalassemia patients.
    European journal of haematology, 2001, Volume: 67, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; beta-Thalassemia; Chelation Therapy; Child; Deferiprone; De

2001

Other Studies

1 other study available for deferiprone and Nervous System Diseases

ArticleYear
Neurological Involvement in a Thalassemic Child Receiving Deferiprone.
    Journal of pediatric hematology/oncology, 2016, Volume: 38, Issue:5

    Topics: Child; Deferiprone; Female; Humans; Iron Chelating Agents; Nervous System Diseases; Pyridones; Thala

2016